Overview

A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy

Status:
Unknown status

Trial end date:
2017-04-01

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to evaluate whether the Apatinib can improve the disease free survival (DFS) of gastric cancer patients in stage IIIB/IIIc, who had completed postoprative adjuvant chemotherapy. Meanwhile, the investigators also will evaluate whether the Apatinib can improve the overall survival (OS), estimate the quality of life of patients have taken the Apatinib and monitor the security of Apatinib.

Phase:

Phase 4

Details

Lead Sponsor:

Tianjin Medical University Cancer Institute and Hospital

Treatments:

Apatinib